Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bie Ping, professor
Southwest Hospital, China
Principal Investigator - Chen Min Shan, professor
Sun Yat-Sen University Cancer Center
Principal Investigator - Chen Yan Ling, professor
Fujian Medical University Union Hospital
Principal Investigator - Ding Yi Tao, professor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator - Dong Jia Hong, professor
Chinese PLA General Hospital
Principal Investigator - Du Qin, professor
Second Affiliated Hospital Zhejiang University School of Medicine
Principal Investigator - Fan Jia, professor
Shanghai Zhongshan Hospital
Study Director - Guo Rong Ping, professor
Sun Yat-Sen University Cancer Center
Principal Investigator - Han Ying, professor
Xijing Hospital
Principal Investigator - Hao Xi Shan, Academician
Tianjin Medical University Cancer Institute and Hospital
Principal Investigator - Jiang Bo, professor
Hunan Provincial People's Hospital
Principal Investigator - Li Wei, professor
The First Affiliated Hospital of Jilin University
Principal Investigator - Liu Ji Yong, professor
Shandong Provincial Hospital
Principal Investigator - Liu Jing Feng, professor
First Affiliated Hospital of Fujian Medical University
Principal Investigator - Liu Jun, professor
Shandong Provincial Hospital
Principal Investigator - Liu Lian Xin, professor
Center of First Affiliated Hospital of Harbin Medical University
Principal Investigator - Liu Qing Guang, professor
First Affiliated Hospital Xi'an Jiaotong University
Principal Investigator - Ma Kuan Sheng, professor
Southwest Hospital, China
Principal Investigator - Sang Xin Ting, professor
Peking Union Medical College Hospital
Principal Investigator - Shi Xue Tao, professor
Shandong Cancer Hospital and Institute
Principal Investigator - Sun Hui Chuan, professor
Shanghai Zhongshan Hospital
Principal Investigator - Tang ZhaoYou, Academician
Shanghai Zhongshan Hospital
Study Chair - Wang Guang Yi, professor
The First Affiliated Hospital of Jilin University
Principal Investigator - Wang Xue Hao, professor
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator - Wang Zhi Ming, professor
Xiangya Hospital of Central South University
Principal Investigator - Wu Jin Shu, professor
Hunan Provincial People's Hospital
Principal Investigator - Wu Meng Chao, Academician
Second Milliary Medical University,Eastern Hepatobiliary Surgery Hosipital
Study Chair - Wu Yu Lian, professor
Second Affiliated Hospital Zhejiang University School of Medicine
Principal Investigator - Xia Xiao Qin, professor
Hubei Cancer Hospital
Principal Investigator - Yan Lv Nan, professor
West China Hospital,Sichuan Universtiy
Principal Investigator - Yan Yi Qun, professor
Second Milliary Medical University,Eastern Hepatobiliary Surgery Hosipital
Principal Investigator - Yang Jia Mei, professor
Second Milliary Medical University,Eastern Hepatobiliary Surgery Hosipital
Study Director - Yang Xun, professor
Sichuan Provincial People's Hospital
Principal Investigator - Ying Min Gang, professor
Fujian Cancer Hospital
Principal Investigator - Zheng Qi Chang, professor
Tongji Medical College,Huazhong University of Science and Technology Wuhan Union Hospital
Principal Investigator - Zheng Shu Sen, Academician
The First Affiliated Hospital of College of Medicine, Zhejiang Universtiy
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fudan University Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 31 Mar 2013
- Completion
- 31 Aug 2013
- Last update posted
- 14 Dec 2011
- Registered enrollment
- 300
- Registry id
- NCT01489566
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.